Efficacy and safety of hepatic arterial infusion chemotherapy combined with donafenib in the treatment of unresectable hepatocellular carcinoma
Donafenib combined with HAIC in the treatment of unresectable HCC patients can notably reduce serum AFP levels, improve hepatic fibrosis, enhance short-term efficacy, prolong PFS, and have a favorable safety profile.
Authors
- Xueqin Gan
- Weijie Xiong
- Tao Wan
Institutions
- Chengdu Fifth People's Hospital (CN)
Publication Details
- Journal
- Asia-Pacific Journal of Clinical Oncology
- Published
- 2024-08-25
- DOI
- https://doi.org/10.1111/ajco.14105
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.74